Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.057 | 0.7 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.068 | 0.7 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.069 | 0.7 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |